


Acura Pharmaceuticals to Host First Quarter 2012 Financial Results Conference Call on May 2, 2012
April 24, 2012 17:30 ET
Acura Pharmaceuticals to Host First Quarter 2012 Financial Results Conference Call on May 2, 2012
PALATINE, IL--(Marketwire - Apr 24, 2012) - Acura Pharmaceuticals, Inc. (
To participate in the live conference call, please dial 888-857-6929 (U.S. and Canada) or 719-457-2658 (international) five to ten minutes prior to the start of the call. The participant passcode is 5534513. A live audio webcast will also be available through the "[ Investors ]" section of the company's website, [ http://www.acurapharm.com ].
A replay of the call will be available beginning May 2, 2012 at 11:30 a.m. ET and ending on May 16, 2012 on the company's website, and by dialing 888-203-1112 (U.S. and Canada) or 719-457-0820 (international). The replay participant code is 5534513.
About Acura Pharmaceuticals
Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address [ medication abuse and misuse ], utilizing its proprietary AVERSION® and IMPEDE technologies. In June 2011, the U.S. Food and Drug Administration, or FDA, approved OXECTA® which incorporates the AVERSION technology. The Company has a development pipeline of additional AVERSION technology products including other opioids, stimulants and benzodiazepines and its IMPEDE technology for pseudoephedrine hydrochloride products.